Patient Adherence and Compliance Market By Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Patient Adherence and Compliance Market
Patient Adherence and Compliance Market: By Type (In-house adherence, Outsourced adherence) & By Technique (Clinical innovation, Patient counseling and education, Software Apps and others) – With Forecast (2016-2021)
Report Code : HCR 0203
Updated Date: 16 February, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Patient Adherence and Compliance– Market Overview
2. Executive Summary
3. Patient Adherence and Compliance– Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Patient Adherence and Compliance– Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Patient Adherence and Compliance Market
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New Entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Patient Adherence and Compliance Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Patient Adherence and Compliance Market– By Type:
   6.1. In-house adherence support
   6.2. Outsourced adherence support
   6.3. Others
7. Patient Adherence and Compliance Market– By Technique: 
   7.1. Clinical innovation
   7.2. Patient counseling and education
   7.3. Software Apps
   7.4. Others
8. Patient Adherence and Compliance Market– By Geography:
   8.1. Introduction
   8.2. Global Study
   8.3. Americas
      8.3.1. North America
      8.3.2. Brazil
      8.3.3. Argentina
      8.3.4. Others
   8.4. Europe
      8.4.1. U.K.
      8.4.2. France
      8.4.3. Germany
      8.4.4. Others
   8.5. APAC
      8.5.1. China
      8.5.2. Japan
      8.5.3. India
      8.5.4. Others
   8.6. ROW
9. Market Entropy
   9.1. New Product Launches
   9.2. M&As, Collaborations, JVs and Partnerships
10. Company Profiles
   10.1. S3 Group
   10.2. Adherence Solutions LLC
   10.3. Drfirst
   10.4. ProteUs Digital Health Inc.
   10.5. HCL Technologies
   10.6. Cognizant
   10.7. Capgemini
   10.8. Smrxt, Inc.
   10.9. Qualcomm Inc.
   10.10. Koninklijke Philips N.V.
   10.11. Adheretech, Inc.
   10.12. Others
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
According to the World Health Organization, “adherence is defined as the extent to which a person's behavior, that involves, taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider.” It essentially refers to the degree to which a patient complies with a treatment regime. Another statistic that the WHO has published is that patient adherence in the case of chronic diseases is as low as 50% in developed countries while it is much lower in developing economies.

Lack of patient adherence and compliance is a major concern for the pharmaceutical companies as it increases the potential need for a higher degree of treatment for patients. This is due to the fact that poor or lack of adherence results in poor health of the patient and in turn results in increased healthcare costs for the healthcare system. It is estimated that about 40% of revenue loss for major pharmaceutical companies is attributed to patient non-adherence and non-compliance. Pharmaceutical companies are investing significantly in order to develop effective solutions to address the growing problem of patient non-adherence and non-compliance.

There are several factors that influence the adherence of patients. Some of these include patient related factors, therapy related factors, disease related factors, cost related factors, factors related to the healthcare system itself, and other socio-economic factors. Patient related factors include the attitude of the patient, the awareness level or lack of it, and misconceptions and perceptions about the disease and its treatment. Cost-related factors are one of the main factors as affordability is a major problem for those without health insurance and also in developing countries.

Patient Adherence and Compliance Market

The patient adherence and compliance market has been segmented as
  • on the basis of type
    • In-house adherence support and Outsourced adherence support.
  • on the basis of technique used
    • Clinical innovation, Patient counseling and education, Software Apps and others

North America accounts for the largest share of the overall patient adherence and compliance market. This can be attributed to the developed healthcare system, increasing geriatric population coupled with the increasing cases of chronic illnesses that are prevalent in the region. 

  • By Geography
    • North America, South America, APAC, Europe, Middle East and Africa

Following are just a few of the companies that are operating in the Patient Adherence and Compliance Market
  • S3 Group
  • Adherence Solutions LLC
  • Qualcomm Inc., 
  • Koninklijke Philips N.V.
  • Adheretech, Inc.
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports